Advertisement

October 01, 2014

Volume 36Issue 10p1295-1482

Editor-in-Chief’s Note

Novel Combination Therapies for Gram Positive Infections

Integrated Partnerships and the Transformation of Pharmaceutical R&D

Featured Content

Frontmatter

Advertisement